Wednesday, July 8, 2026

Drug profile · INN

colistin sulfate

colistin sulfate (COLY-MYCIN S) is a cell outer membrane inhibitor. Route of administration: otic. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — colistin sulfate
US status
approved
Class
Route
OTIC
Patents
0
Programs
0
Data quality
0.84

Quick answer

colistin sulfate (COLY-MYCIN S) is a cell outer membrane inhibitor. Route of administration: otic. Current US regulatory status: approved.

Key facts

INN colistin sulfate
Brand COLY-MYCIN S
Mechanism Cell outer membrane inhibitor
Target Cell outer membrane
Route OTIC
Formulation SUSPENSION

Mechanism of action

Cell outer membrane inhibitor

Primary target: Cell outer membrane

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. telavancin hydrochloride Cell outer membrane inhibitor
  2. polymyxin b sulfate Cell outer membrane inhibitor

Frequently asked questions

What is colistin sulfate?

colistin sulfate (COLY-MYCIN S) is a cell outer membrane inhibitor. Route of administration: otic. Current US regulatory status: approved.

What is the brand name for colistin sulfate?

COLY-MYCIN S is a marketed brand name for colistin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of colistin sulfate?

colistin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.